Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.
The current price of NSIS/N is 911.11 MXN — it hasn't changed in the past 24 hours. Watch NOVONESIS (NOVOZYMES) B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange NOVONESIS (NOVOZYMES) B stocks are traded under the ticker NSIS/N.
NSIS/N stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in NOVONESIS (NOVOZYMES) B price.
We've gathered analysts' opinions on NOVONESIS (NOVOZYMES) B future price: according to them, NSIS/N price has a max estimate of 1389.14 MXN and a min estimate of 935.00 MXN. Watch NSIS/N chart and read a more detailed NOVONESIS (NOVOZYMES) B stock forecast: see what analysts think of NOVONESIS (NOVOZYMES) B and suggest that you do with its stocks.
NSIS/N reached its all-time high on Apr 4, 2024 with the price of 911.11 MXN, and its all-time low was 911.11 MXN and was reached on Mar 11, 2024. View more price dynamics on NSIS/N chart. See other stocks reaching their highest and lowest prices.
NSIS/N stock is 0% volatile and has beta coefficient of 0.24. Track NOVONESIS (NOVOZYMES) B stock price on the chart and check out the list of the most volatile stocks — is NOVONESIS (NOVOZYMES) B there?
Today NOVONESIS (NOVOZYMES) B has the market capitalization of 507.87 B, it has decreased by 2.15% over the last week.
NOVONESIS (NOVOZYMES) B is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
NSIS/N earnings for the last quarter are 8.73 MXN per share, whereas the estimation was 9.34 MXN resulting in a −6.56% surprise. The estimated earnings for the next quarter are 11.37 MXN per share. See more details about NOVONESIS (NOVOZYMES) B earnings.
NOVONESIS (NOVOZYMES) B revenue for the last quarter amounts to 17.23 B MXN, despite the estimated figure of 17.74 B MXN. In the next quarter, revenue is expected to reach 19.02 B MXN.
NSIS/N net income for the last quarter is 1.75 B MXN, while the quarter before that showed 2.31 B MXN of net income which accounts for −23.93% change. Track more NOVONESIS (NOVOZYMES) B financial stats to get the full picture.
NOVONESIS (NOVOZYMES) B dividend yield was 1.67% in 2023, and payout ratio reached 56.80%. The year before the numbers were 1.71% and 45.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 14, 2024, the company has 6.76 K employees. See our rating of the largest employees — is NOVONESIS (NOVOZYMES) B on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVONESIS (NOVOZYMES) B EBITDA is 14.67 B MXN, and current EBITDA margin is 32.72%. See more stats in NOVONESIS (NOVOZYMES) B financial statements.
Like other stocks, NSIS/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVONESIS (NOVOZYMES) B stock right from TradingView charts — choose your broker and connect to your account.